Onesource Specialty Pharma Dokumen
Dokumen
0
Ticker
ONESOURCE.NS
ISIN
INE013P01021
Onesource Specialty Pharma SEC Filings
Tipe | Laporan | Tanggal |
|---|---|---|
| Tidak ada dokumen tersedia | ||
Onesource Specialty Pharma Dokumen 2026
Halaman ini berisi semua dokumen resmi dan SEC filings untuk saham Onesource Specialty Pharma (ONESOURCE.NS, ISIN: INE013P01021). Ini termasuk laporan tahunan (Form 10-K), laporan kuartal (Form 10-Q), dan transaksi insider (Form 4). Saat ini 0 dokumen tersedia. Data diperbarui secara teratur untuk memberikan investor gambaran lengkap tentang pengajuan regulasi Onesource Specialty Pharma.
Onesource Specialty Pharma Analisis saham
Onesource Specialty Pharma Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities.